2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2570
  



  

  
Submitter : 
  

  
Mrs. Joan Walsh
  

  
Date & Time: 
  

  
12/05/2006 10:12:24
  



  

  
Organization : 
  

  
Mrs. Joan Walsh
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Regarding the Food and Drug Administration (FDA) draft of guidelines to the pharmaceutical industry regarding the development of vaccines from various cell lines to combat new infectious diseases such as SARS and new flu strains. Some of these cells lines come from ethical sources while other cell lines originated from the tissue of aborted children. 





 There are a number of cell lines which have originated from ethical and completely non-controversial sources for the development of vaccines. I support the FDA recommending that pharmaceutical companies use these cells from non-controversial sources instead of cells derived from aborted children.

I am concerned with the possibility of using a vaccine which was created by using cells taken from aborted children.